Long-term effects of antihypertensive medications on bone mineral density in men older than 55 years

Abstract

IntroductionIn this study, we investigated the effects of long-term antihypertensive treatment with calcium channel blockers or beta blockers on the bone mineral density of maxilla, as determined by cone-beam computed tomography (CBCT).Material and methodsThis retrospective study was conducted on CBCT images of men older than 55 years who had received different dental indications. Data were grouped into three categories according to the antihypertensive medication history of the patients: group A included patients who had been taking beta-blocker treatment for more than 5 years, group B included patients who had been taking calcium channel blocker treatment for more than 5 years, and the control group included patients who had never used any hypertensive medications before.ResultsStatistically significant differences were observed between the beta blocker and calcium channel blocker groups.ConclusionIn hypertension treatment, beta blockers may be preferred to calcium channel blockers in patients at high risk for osteoporosis and bone resorption.

Demographic features of patients with concomitant facial fractures and closed head injuries in Maricopa, Arizona

“…CBCT is currently used to measure preoperative BMD for dental implant placement 25 or to assess for medication-induced osteoporosis. 26 BMD, as measured by dual-energy X-ray absorptiometry is termed areal bone mineral density (aBMD), and racial differences in aBMD have been useful measures of relative bone strength, but the studies using these measurements appear to have focused on the female vertebrae and femora. Such studies have shown that African Americans have the greatest aBMD, followed by whites, Hispanics, and then Native Americans.…”

Cav1.2 regulates osteogenesis of bone marrow‐derived mesenchymal stem cells via canonical Wnt pathway in age‐related osteoporosis

“…Calcium channels, which are in charge of calcium transportation into and out of cells and organelles, play an important role in aging (Surmeier, ; Warnier et al, ). In terms of bone aging, numerous studies have indicated the relationship between disruption of calcium channels and age‐related bone mass loss (Agacayak et al, ; Shimizu et al, ). There are several kinds of calcium channels, among which voltage‐gated Ca 2+ channels (VGCCs) are important components.…”

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength

“…Сканы были разделены на три группы в зависимости от типа кардиологического препарата, который пациенты принимали не менее 5 лет: 1 группа -БАБ, 2 группа -АК, 3 -пациенты, не принимавшие сердечно-сосудистые препараты. Объемная МПК у пациентов, принимающих длительно БАБ, была значимо выше, чем в группах АК и контрольной, в связи с чем авторы сделали вывод, что БАБ предпочтительней использовать у пациентов с АГ и высоким риском переломов, связанных с хрупкостью костной ткани [51]. В то же время нет исследований, подтверждающих строгую связь между локальным остеопорозом челюсти и системным остеопорозом.…”